Vor Biopharma
Vor Biopharma Logo
Logos are displayed for identification only. Logokit is not affiliated with, endorsed by, or sponsored by the companies shown.
About Vor Biopharma
Vor BioPharma Inc is a clinical-stage biotechnology company focused on developing innovative cell and genome engineering therapies for blood cancers, particularly acute myeloid leukemia (AML). Its lead product candidate, tremtelectogene empogeditemcel (trem-cel), is an engineered hematopoietic stem cell therapy in clinical trials for AML and other hematological malignancies. The company is also advancing antibody drug conjugate and CAR-T therapies targeting CD33, as well as multiplex-engineered treatment systems for AML. Vor BioPharma leverages proprietary platforms in genome engineering, HSC biology, and CAR-T cell technology to create targeted therapies that aim to selectively destroy cancer cells while sparing healthy cells.
Address
100 Cambridgepark Drive, Suite 101
Cambridge, 02140
United States
Year founded
2015
Number of employees
100-200
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Add Vor Biopharma logo and brand data to your app or website
Embed this logo using a simple HTML tag, or access structured brand data with a single call to our API.
<img src="https://img.logokit.com/vorbio.com" />
Report inaccurate data
Request an update to help us keep the brand up-to-date.
